:format(webp)/cdn.mskdoctors.com/storage/2026/8/mOM8evNOHkiXmiESVwOZGPQ1PHyq8aid.jpg)
ChondroFiller or Arthrosamid for knee cartilageChondroFiller and Arthrosamid are not interchangeable fillers — they address different anatomical targets within the knee. ChondroFiller is a collagen scaffold placed directly on the cartilage surface to recruit the patient's own repair cells; Arthrosamid is a permanent hydrogel in the synovial lining that provides mechanical cushioning.ChondroFiller and Arthrosamid are not interchangeable fillers — they address different anatomical targets within the knee. ChondroFiller is a collagen scaffold placed directly on the cartilage surface to recruit the patient's own repair cells; Arthrosamid is a permanent hydrogel in the synovial lining that provides mechanical cushioning.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/gTdsEPtfmXpaOq7B23DkXhgMPJns8Ypv.jpg)
What IKDC and MOCART data show about ChondroFillerChondroFiller injection improves knee function by an average of 30 points on the IKDC scale — double the clinically meaningful threshold — across independent studies, though evidence derives from small cohorts of younger patients with focal cartilage defects.ChondroFiller injection improves knee function by an average of 30 points on the IKDC scale — double the clinically meaningful threshold — across independent studies, though evidence derives from small cohorts of younger patients with focal cartilage defects.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/YhFnfO9lzvEXOlGlxEL9EE2JKrJyBfB0.jpg)
ChondroFiller injection safety and the questions to askChondroFiller shows a near-zero complication rate across published trials and over 19,000 post-market cases; fibrous tissue forms only when the scaffold is overfilled, making precise dose determination from pre-procedure MRI the key safeguard.ChondroFiller shows a near-zero complication rate across published trials and over 19,000 post-market cases; fibrous tissue forms only when the scaffold is overfilled, making precise dose determination from pre-procedure MRI the key safeguard.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/qaIZGeooLUJtaK5Ndmgn8681psd7lMhV.jpg)
ChondroFiller versus hyaluronic acid for cartilage defectsChondroFiller fills discrete cartilage defects using a cell-recruiting scaffold; hyaluronic acid treats diffuse osteoarthritis through joint lubrication. They address different pathologies, and the choice depends on imaging, not on how much pain a patient experiences.ChondroFiller fills discrete cartilage defects using a cell-recruiting scaffold; hyaluronic acid treats diffuse osteoarthritis through joint lubrication. They address different pathologies, and the choice depends on imaging, not on how much pain a patient experiences.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/QrfuPSrluQSuTfY26E2s7bPfm9fOFncs.jpg)
ChondroFiller injection safety: what the evidence showsOver 19,000 ChondroFiller injections have been administered globally with no serious adverse effects reported; reoperation rates of 3–8% fall well below surgical alternatives such as microfracture (up to 41%) and ACI/MACI (up to 37%).Over 19,000 ChondroFiller injections have been administered globally with no serious adverse effects reported; reoperation rates of 3–8% fall well below surgical alternatives such as microfracture (up to 41%) and ACI/MACI (up to 37%).
:format(webp)/cdn.mskdoctors.com/storage/2026/7/Z5ahPIurHVWU8aytBhy70twbvuGSfEAl.jpg)
ChondroFiller injection for hip cartilage defectsChondroFiller is an injectable collagen scaffold that repairs hip cartilage by recruiting the body's own repair cells; delivered under local anaesthesia as an outpatient procedure, it shows 70–85% symptom relief in small published series, though long-term data beyond five years are absent.ChondroFiller is an injectable collagen scaffold that repairs hip cartilage by recruiting the body's own repair cells; delivered under local anaesthesia as an outpatient procedure, it shows 70–85% symptom relief in small published series, though long-term data beyond five years are absent.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/nJpuPYmYxVIJuCuke5TmcJtXlcYJxImS.jpg)
ChondroFiller or Arthrosamid for your kneeChondroFiller repairs focal cartilage defects via a collagen scaffold, and Arthrosamid provides cushioning by integrating into the synovial lining — because they target different anatomical structures, the MRI scan, not patient preference, determines which injection is appropriate.ChondroFiller repairs focal cartilage defects via a collagen scaffold, and Arthrosamid provides cushioning by integrating into the synovial lining — because they target different anatomical structures, the MRI scan, not patient preference, determines which injection is appropriate.
:format(webp)/cdn.mskdoctors.com/storage/2026/6/AQZR5B1QMTa6MDznK1cq7XGkHnmvSm2W.jpg)
Choosing a ChondroFiller Specialist in the UKChondroFiller is a CE-marked Class III medical device, requiring the same regulatory infrastructure as surgically implanted hardware: specialist ordering pipelines, cold-chain management, and clinical protocols that only a handful of UK centres currently maintain.ChondroFiller is a CE-marked Class III medical device, requiring the same regulatory infrastructure as surgically implanted hardware: specialist ordering pipelines, cold-chain management, and clinical protocols that only a handful of UK centres currently maintain.
:format(webp)/cdn.mskdoctors.com/storage/2026/6/kY3aOCrk3PYMR2xZRyN2DFXsNPQyzwu8.jpg)
What the ChondroFiller evidence actually showsChondroFiller, a collagen scaffold, increases knee function scores by 30 points at three years — roughly double the clinical significance threshold — but no large independent randomised trial has been completed.ChondroFiller, a collagen scaffold, increases knee function scores by 30 points at three years — roughly double the clinical significance threshold — but no large independent randomised trial has been completed.
:format(webp)/cdn.mskdoctors.com/storage/2026/6/BHqWTZ0EoDO53RySglieS2V8xkzxUD9H.jpg)
ChondroFiller duration vs hyaluronic acid and ArthrosamidChondroFiller's repair tissue outlasts the scaffold itself: the collagen dissolves within two years, but tissue built by the patient's own progenitor cells persists for three to five years.ChondroFiller's repair tissue outlasts the scaffold itself: the collagen dissolves within two years, but tissue built by the patient's own progenitor cells persists for three to five years.
:format(webp)/cdn.mskdoctors.com/storage/2026/6/DoHi2Wz6TOQkmLw2hCNUNtfjocgmpoAf.jpg)
Who qualifies for ChondroFiller injectionChondroFiller recruits the patient's own cells into a collagen scaffold placed within focal cartilage defects; candidacy requires mechanical joint stability and absence of widespread degeneration.ChondroFiller recruits the patient's own cells into a collagen scaffold placed within focal cartilage defects; candidacy requires mechanical joint stability and absence of widespread degeneration.
:format(webp)/cdn.mskdoctors.com/storage/2026/6/Ftb0eLP1qk86rzkUGQIcwelqCKAR75gI.jpg)
ChondroFiller injection vs PRP for cartilage repairChondroFiller fills focal cartilage defects with a collagen scaffold; PRP modulates inflammation in diffuse wear. MRI findings, not symptoms, determine which applies.ChondroFiller fills focal cartilage defects with a collagen scaffold; PRP modulates inflammation in diffuse wear. MRI findings, not symptoms, determine which applies.
